Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Nucleocapsid protein
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Exosomal vaccine
Nucleocapsid protein
Potential treatment - pre-clinical evidence Experimental Vaccine Jul/29/2022
BNT162b2
Nucleocapsid protein
Approved by FDA Experimental Vaccine Jun/22/2022
LSNME/SW1
Nucleocapsid protein
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/01/2021
(-)-Gallocatechin gallate
Nucleocapsid protein
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/09/2021
Glycyrrhizic acid
Nucleocapsid protein
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021
rLVS ΔcapB/SCoV2 MN
Nucleocapsid protein
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/30/2021
Mefuparib hydrochloride
Nucleocapsid protein
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/26/2021
Irbesartan
Nucleocapsid protein
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Alvimopan
Nucleocapsid protein
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Darifenacin
Nucleocapsid protein
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Nebivolol
Nucleocapsid protein
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021
Bictegravir
Nucleocapsid protein
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021
Cefuroxime
Nucleocapsid protein
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/01/2021
Cefotaxime
Nucleocapsid protein
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/01/2021
Ceftriaxone
Nucleocapsid protein
Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/01/2021
LbuCas13a N3.2
Nucleocapsid protein
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/03/2021
1,2,3-triazole-phtalimide compound E40
Nucleocapsid protein
Potential treatment - theoretical effect Experimental Antiviral Jan/18/2021
Theaflavin
Nucleocapsid protein
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020
sMVA-N/S
Nucleocapsid protein
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020